Compare Stocks: EQX, BIRK, and IMCR

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIRK Birkenstock	$33.75 -1.4%	$40.39	$31.12 ▼ $51.37	$6.09B	1.28	3.30 million shs	1.40 million shs
EQX Equinox Gold	$12.63 +3.7%	$10.64	$8.48 ▼ $18.96	$14.22B	1.32	15.37 million shs	9.67 million shs
IMCR Immunocore	$37.37 +1.4%	$34.25	$27.56 ▼ $40.71	$1.90B	0.74	402,129 shs	220,689 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.

This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIRK Birkenstock	-2.29%	-2.99%	-11.88%	-18.99%	-34.53%
EQX Equinox Gold	-5.29%	-12.88%	+36.09%	+8.56%	+39.04%
IMCR Immunocore	+1.49%	-1.44%	+9.02%	+28.66%	+14.40%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BIRK Birkenstock	$33.75 -1.4%	$40.39	$31.12 ▼ $51.37	$6.09B	1.28	3.30 million shs	1.40 million shs
EQX Equinox Gold	$12.63 +3.7%	$10.64	$8.48 ▼ $18.96	$14.22B	1.32	15.37 million shs	9.67 million shs
IMCR Immunocore	$37.37 +1.4%	$34.25	$27.56 ▼ $40.71	$1.90B	0.74	402,129 shs	220,689 shs

7 Blue-Chip Stocks to Add To Your Forever Portfolio

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BIRK Birkenstock	-2.29%	-2.99%	-11.88%	-18.99%	-34.53%
EQX Equinox Gold	-5.29%	-12.88%	+36.09%	+8.56%	+39.04%
IMCR Immunocore	+1.49%	-1.44%	+9.02%	+28.66%	+14.40%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BIRK Birkenstock	2.67	Moderate Buy	$53.91	59.70% Upside
EQX Equinox Gold	3.00	Buy	$13.00	2.93% Upside
IMCR Immunocore	2.69	Moderate Buy	$56.38	50.86% Upside

Current Analyst Ratings Breakdown

Latest EQX, BIRK, and IMCR Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/24/2026	IMCR Immunocore	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
8/21/2026	IMCR Immunocore	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Overweight	$50.00
8/14/2026	BIRK Birkenstock	Telsey Advisory Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$45.00 ➝ $50.00
8/14/2026	BIRK Birkenstock	Sanford C. Bernstein Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Market Perform	$50.00 ➝ $55.00
8/14/2026	BIRK Birkenstock	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$60.00
8/14/2026	BIRK Birkenstock	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$60.00
8/7/2026	EQX Equinox Gold	Scotiabank Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
8/7/2026	IMCR Immunocore	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$43.00
8/6/2026	BIRK Birkenstock	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$60.00
8/5/2026	IMCR Immunocore	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
8/4/2026	BIRK Birkenstock	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$77.00 ➝ $76.00

(Data available from 9/2/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BIRK Birkenstock	$2.27B	2.65	$2.66 per share	12.67	$18.31 per share	1.84
EQX Equinox Gold	$1.82B	8.11	$0.72 per share	17.48	$5.45 per share	2.32
IMCR Immunocore	$400.02M	4.81	N/A	N/A	$8.15 per share	4.59

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BIRK Birkenstock	$385.46M	$2.13	15.82	12.79	1.37	14.82%	13.36%	7.21%	N/A
EQX Equinox Gold	$221.47M	$0.54	12.63	9.64	N/A	26.30%	10.91%	6.46%	11/4/2026 (Estimated)
IMCR Immunocore	-$35.51M	-$0.37	N/A	149.48	N/A	-4.20%	-4.54%	-1.66%	11/5/2026 (Estimated)

Latest EQX, BIRK, and IMCR Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q3 2026	BIRK Birkenstock	$0.88	$0.86	-$0.02	$0.68	$827.39 million	$834.65 million
8/7/2026	Q2 2026	IMCR Immunocore	-$0.01	-$0.02	-$0.01	-$0.02	$148.57 million	N/A
8/5/2026	Q2 2026	EQX Equinox Gold	$0.1709	$0.16	-$0.0109	N/A	$775.79 million	$769.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BIRK Birkenstock	N/A	N/A	N/A	N/A	N/A
EQX Equinox Gold	$0.09	0.71%	N/A	16.67%	N/A
IMCR Immunocore	N/A	N/A	N/A	N/A	N/A

Latest EQX, BIRK, and IMCR Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
8/5/2026	EQX Equinox Gold	quarterly	$0.0225	0.71%	8/19/2026	8/19/2026	9/2/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BIRK Birkenstock	0.67	3.78	2.09
EQX Equinox Gold	0.09	1.33	0.77
IMCR Immunocore	0.94	4.47	4.44

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BIRK Birkenstock	19.93%
EQX Equinox Gold	38.85%
IMCR Immunocore	84.50%

Insider Ownership

Company	Insider Ownership
BIRK Birkenstock	N/A
EQX Equinox Gold	8.35%
IMCR Immunocore	10.10%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BIRK Birkenstock	8,400	177.89 million	N/A	Optionable
EQX Equinox Gold	5,219	1.17 billion	1.07 billion	Not Optionable
IMCR Immunocore	320	51.50 million	46.30 million	Optionable

EQX, BIRK, and IMCR Headlines

Recent News About These Companies

Analysts Set Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) PT at $56.38

September 2 at 1:59 AM | americanbankingnews.com

Immunocore to present at upcoming investor conferences

September 1 at 7:00 AM | globenewswire.com

Immunocore Holdings PLC Sponsored ADR (NASDAQ:IMCR) Receives Average Rating of "Moderate Buy" from Brokerages

August 28, 2026 | marketbeat.com

Bank of America Corp DE Trims Stock Position in Immunocore Holdings PLC Sponsored ADR $IMCR

August 27, 2026 | marketbeat.com

Immunocore (NASDAQ:IMCR) Upgraded at TD Cowen

August 27, 2026 | americanbankingnews.com

Will Kimmtrak Continue to Aid IMCR's Growth Through the Rest of 2026?

August 25, 2026 | zacks.com

TD Cowen Upgrades Immunocore (NASDAQ:IMCR) to "Strong-Buy"

August 25, 2026 | marketbeat.com

JPMorgan Chase & Co. Begins Coverage on Immunocore (NASDAQ:IMCR)

August 23, 2026 | americanbankingnews.com

Immunocore (NASDAQ:IMCR) Earns Overweight Rating from Analysts at JPMorgan Chase & Co.

August 21, 2026 | marketbeat.com

Q3 Earnings Estimate for Immunocore Issued By HC Wainwright

August 14, 2026 | marketbeat.com

Q3 Earnings Forecast for Immunocore Issued By HC Wainwright

August 13, 2026 | marketbeat.com

IMCR Jumps 21.2% in 3 Months as Kimmtrak Growth Fuels More Momentum

August 10, 2026 | zacks.com

Is IMCR Worth Buying as Kimmtrak Growth Meets a Premium Valuation?

August 10, 2026 | zacks.com

IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss

August 10, 2026 | zacks.com

Immunocore outlines TEBE-AM data as early as end of 2026 while scaling KIMMTRAK beyond ~1,000 patients per year

August 7, 2026 | seekingalpha.com

Immunocore's Q2 Earnings Miss Estimates, Kimmtrak Aids Y/Y Revenues

August 7, 2026 | zacks.com

Wall Street Analysts See a 77.91% Upside in Immunocore (IMCR): Can the Stock Really Move This High?

August 7, 2026 | zacks.com

Immunocore (NASDAQ:IMCR) Rating Increased to Strong-Buy at Zacks Research

August 7, 2026 | marketbeat.com

Immunocore Holdings plc 2026 Q2 - Results - Earnings Call Presentation

August 7, 2026 | seekingalpha.com

Immunocore (NASDAQ:IMCR) Issues Earnings Results

August 6, 2026 | marketbeat.com

Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Kimtrak Growth and Pipeline ...

August 6, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

EQX, BIRK, and IMCR Company Descriptions

Birkenstock NYSE:BIRK

$33.75 -0.50 (-1.45%)

Closing price 03:59 PM Eastern

Extended Trading

$33.93 +0.18 (+0.52%)

As of 07:30 PM Eastern

Birkenstock Holding plc manufactures and sells footwear products. It also offers sandals, shoes, closed-toe silhouettes, skincare products, and accessories. The company sells its products through e-commerce sites and a network of owned retail stores, as well as business-to-business channels. It operates in the United States, Brazil, Canada, Mexico, Europe, APMA, and internationally. Birkenstock Holding plc was founded in 1774 and is based in London, the United Kingdom. Birkenstock Holding plc is a subsidiary of BK LC Lux MidCo S.à r.l.

Equinox Gold NYSEAMERICAN:EQX

$12.63 +0.45 (+3.69%)

Closing price 04:10 PM Eastern

Extended Trading

$12.68 +0.05 (+0.41%)

As of 08:00 PM Eastern

Equinox Gold Corp. engages in the exploration, acquisition, development, and operation of mineral properties in the Americas. It explores gold and silver deposits. It holds interest in properties in California located in the United States; Guerrero State located in Mexico; Maranhão, Bahia, and Mina Gerais state located in Brazil; and Ontario, Canada. The company was formerly known as Trek Mining Inc. and changed its name to Equinox Gold Corp. in December 2017. Equinox Gold Corp. was incorporated in 2007 and is headquartered in Vancouver, Canada.

Immunocore NASDAQ:IMCR

$37.37 +0.51 (+1.38%)

Closing price 04:00 PM Eastern

Extended Trading

$37.34 -0.03 (-0.08%)

As of 07:30 PM Eastern

Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. It also develops other programs for oncology, including tebentafusp that is in Phase 2/3 clinical trial to treat advanced cutaneous melanoma. In addition, the company's product pipeline comprises IMC-F106C, which is in a Phase 3 clinical trial to treat first line advanced cutaneous melanoma; and in a Phase 1/2 clinical trial in multiple tumor types, such as platinum resistant ovarian, non-small cell lung, and endometrial carcinoma. Further, it develops IMC-R117C, which is in phase 1 clinical trial to treat colorectal and gastrointestinal cancers; IMC-M113V, which is in phase 1 clinical trial to treat human immunosuppression virus; IMC-I109V, which is in a Phase I clinical trial in patients with chronic hepatitis B virus; IMC-T119C, which is in preclinical trial for multiple solid tumor cancers; IMC-P115C, which is in preclinical trial to treat multiple solid tumor cancers; and IMC-S118AI to treat type 1 diabetes and is in preclinical trial. Immunocore Holdings plc was founded in 1999 and is headquartered in Abingdon, the United Kingdom.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EQX, BIRK, and IMCR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EQX, BIRK, and IMCR Earnings

Compare Dividends

Latest EQX, BIRK, and IMCR Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EQX, BIRK, and IMCR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

EQX, BIRK, and IMCR Company Descriptions

Birkenstock NYSE:BIRK

Equinox Gold NYSEAMERICAN:EQX

Immunocore NASDAQ:IMCR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest EQX, BIRK, and IMCR Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest EQX, BIRK, and IMCR Earnings

Compare Dividends

Latest EQX, BIRK, and IMCR Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

EQX, BIRK, and IMCR Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

EQX, BIRK, and IMCR Company Descriptions

Birkenstock NYSE:BIRK

Equinox Gold NYSEAMERICAN:EQX

Immunocore NASDAQ:IMCR

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools